MRTX logo

Mirati Therapeutics (MRTX) Revenue

Annual Revenue

$12.44 M
-$59.66 M-82.75%

December 31, 2022

Summary

Performance

1-Year Change

-82.75%

3-Year Change

+272.89%

5-Year Change

-

15-Year Change

-

MRTX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$59.37 M
MRTX annual revenue is currently -79.05% lower than the consensus analysts' forecast

High & Low

All-time High

$72.09 M
MRTX annual revenue is currently -82.75% below its historical high of $72.09 million

3-Year Low

$12.44 M
MRTX annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
MRTX previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
MRTX next annual earnings announcement has not yet been scheduled

OtherMRTXprofitabilitymetrics:

Annual EPS

-$13.18
MRTX annual earnings per share is -$13.18

Annual Net Income

-$740.87 M
MRTX annual net profit is -$740.87 million

Annual Operating Profit

-$759.59 M
MRTX annual operating income is -$759.59 million

Annual Gross Profit

$11.84 M
MRTX annual gross profit is $11.84 million

Quarterly Revenue

$16.40 M
+$2.71 M+19.80%

September 30, 2023

Summary

Performance

3-Month Change

+19.8%

1-Year Change

+201.97%

3-Year Change

+43.56%

5-Year Change

-

MRTX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$22.09 M
MRTX quarterly revenue is currently -25.76% lower than the consensus analysts' forecast

High & Low

All-time High

$71.79 M
MRTX quarterly revenue is currently -77.16% below its historical high of $71.79 million

3-Year Low

$299.00 K
MRTX quarterly revenue is currently +5384.95% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
MRTX previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
MRTX next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$14.71 M
MRTX quarterly gross profit is $14.71 million

Quarterly Operating Profit

-$172.05 M
MRTX quarterly operating income is -$172.05 million

Quarterly Net Income

-$161.90 M
MRTX quarterly net profit is -$161.90 million

Quarterly EPS

-$2.49
MRTX quarterly earnings per share is -$2.49

TTM Revenue

$38.19 M
+$10.97 M+40.29%

September 30, 2023

Summary

Performance

3-Month Change

+40.29%

1-Year Change

+223.63%

3-Year Change

+212.61%

5-Year Change

+1045.16%

MRTX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$59.35 M
MRTX TTM revenue is currently -35.65% lower than the consensus analysts' forecast

High & Low

All-time High

$78.16 M
MRTX TTM revenue is currently -51.14% below its historical high of $78.16 million

3-Year Low

$11.80 M
MRTX TTM revenue is currently +223.63% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
MRTX previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
MRTX next earnings announcement has not yet been scheduled

OtherMRTXprofitabilitymetrics:

TTM Gross Profit

$33.80 M
MRTX TTM gross profit is $33.80 million

TTM Operating Profit

-$764.87 M
MRTX TTM operating income is -$764.87 million

TTM Net Income

-$725.88 M
MRTX TTM net profit is -$725.88 million

TTM EPS

-$12.22
MRTX TTM earnings per share is -$12.22

MRTX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-82.8%+202.0%+223.6%
3 y3 years+272.9%+43.6%+212.6%
5 y5 years--+1045.2%

MRTX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-82.7%at lowat high-98.2%-51.1%-69.1%
5 y5-year-82.7%-73.2%-77.2%-98.4%-51.1%-93.8%
alltimeall time-82.7%-80.8%-77.2%-99.6%-51.1%-95.9%

Mirati Therapeutics Revenue History

DateAnnualQuarterlyTTM
Sep 2023
-
$16.40 M(+19.8%)
$38.19 M(+40.3%)
Jun 2023
-
$13.69 M(+91.0%)
$27.22 M(+44.1%)
Mar 2023
-
$7.17 M(+667.3%)
$18.89 M(+51.9%)
Dec 2022
$12.44 M(-82.7%)
$934.00 K(-82.8%)
$12.44 M(+5.4%)
Sep 2022
-
$5.43 M(+1.3%)
$11.80 M(-84.9%)
Jun 2022
-
$5.36 M(+656.3%)
$78.16 M(+7.4%)
Mar 2022
-
$709.00 K(+137.1%)
$72.80 M(+1.0%)
Dec 2021
$72.09 M(+438.1%)
$299.00 K(-99.6%)
$72.09 M(-1.9%)
Sep 2021
-
$71.79 M(+4103.3%)
$73.50 M(+448.6%)
Dec 2020
$13.40 M(+301.7%)
$1.71 M(-85.0%)
$13.40 M(+9.7%)
Sep 2020
-
$11.42 M(+4178.7%)
$12.22 M(+418.1%)
Mar 2020
-
$267.00 K(-49.2%)
$2.36 M(-29.3%)
Dec 2019
$3.33 M(-74.2%)
$526.00 K(-46.8%)
$3.33 M(-46.8%)
Sep 2019
-
$988.00 K(+71.2%)
$6.27 M(+18.7%)
Jun 2019
-
$577.00 K(-53.6%)
$5.28 M(+12.3%)
Mar 2019
-
$1.24 M(-64.0%)
$4.70 M(-63.6%)
Dec 2018
$12.93 M(+326.8%)
$3.46 M(-63.5%)
$12.93 M(+36.5%)
Mar 2018
-
$9.47 M(+1794.5%)
$9.47 M(+195.9%)
Dec 2011
$3.03 M(+26.8%)
$499.70 K(+673.5%)
$3.20 M(-10.2%)
Sep 2011
-
$64.60 K(-95.1%)
$3.56 M(-12.4%)
Jun 2011
-
$1.32 M(-0.4%)
$4.07 M(+25.6%)
Mar 2011
-
$1.32 M(+52.8%)
$3.24 M(+35.9%)
Dec 2010
$2.39 M
$864.10 K(+51.9%)
$2.38 M(+17.5%)
Sep 2010
-
$568.90 K(+17.1%)
$2.03 M(+6.0%)
DateAnnualQuarterlyTTM
Jun 2010
-
$485.70 K(+4.5%)
$1.91 M(+8.6%)
Mar 2010
-
$465.00 K(-8.8%)
$1.76 M(-32.6%)
Dec 2009
$2.88 M(-88.1%)
$509.80 K(+12.4%)
$2.62 M(-79.6%)
Sep 2009
-
$453.70 K(+35.8%)
$12.80 M(-28.3%)
Jun 2009
-
$334.20 K(-74.7%)
$17.85 M(-17.8%)
Mar 2009
-
$1.32 M(-87.7%)
$21.72 M(-11.4%)
Dec 2008
$24.24 M(+54.8%)
$10.69 M(+94.0%)
$24.51 M(+32.2%)
Sep 2008
-
$5.51 M(+31.0%)
$18.55 M(+10.9%)
Jun 2008
-
$4.21 M(+2.4%)
$16.72 M(+4.8%)
Mar 2008
-
$4.11 M(-13.0%)
$15.94 M(+7.0%)
Dec 2007
$15.65 M(+13.8%)
$4.72 M(+28.3%)
$14.91 M(+17.5%)
Sep 2007
-
$3.68 M(+7.3%)
$12.69 M(-24.0%)
Jun 2007
-
$3.43 M(+11.8%)
$16.70 M(+7.2%)
Mar 2007
-
$3.07 M(+22.6%)
$15.57 M(+13.7%)
Dec 2006
$13.75 M(+138.8%)
$2.50 M(-67.4%)
$13.70 M(+13.0%)
Sep 2006
-
$7.69 M(+233.0%)
$12.12 M(+105.9%)
Jun 2006
-
$2.31 M(+92.7%)
$5.89 M(+12.0%)
Mar 2006
-
$1.20 M(+29.7%)
$5.25 M(-6.3%)
Dec 2005
$5.76 M(-18.3%)
$923.50 K(-36.5%)
$5.61 M(+19.7%)
Sep 2005
-
$1.45 M(-13.3%)
$4.68 M(+45.1%)
Jun 2005
-
$1.68 M(+8.4%)
$3.23 M(+108.4%)
Mar 2005
-
$1.55 M
$1.55 M
Dec 2004
$7.05 M(-8.6%)
-
-
Dec 2003
$7.71 M
-
-

FAQ

  • What is Mirati Therapeutics annual revenue?
  • What is the all time high annual revenue for Mirati Therapeutics?
  • What is Mirati Therapeutics annual revenue year-on-year change?
  • What is Mirati Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Mirati Therapeutics?
  • What is Mirati Therapeutics quarterly revenue year-on-year change?
  • What is Mirati Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Mirati Therapeutics?
  • What is Mirati Therapeutics TTM revenue year-on-year change?

What is Mirati Therapeutics annual revenue?

The current annual revenue of MRTX is $12.44 M

What is the all time high annual revenue for Mirati Therapeutics?

Mirati Therapeutics all-time high annual revenue is $72.09 M

What is Mirati Therapeutics annual revenue year-on-year change?

Over the past year, MRTX annual revenue has changed by -$59.66 M (-82.75%)

What is Mirati Therapeutics quarterly revenue?

The current quarterly revenue of MRTX is $16.40 M

What is the all time high quarterly revenue for Mirati Therapeutics?

Mirati Therapeutics all-time high quarterly revenue is $71.79 M

What is Mirati Therapeutics quarterly revenue year-on-year change?

Over the past year, MRTX quarterly revenue has changed by +$10.97 M (+201.97%)

What is Mirati Therapeutics TTM revenue?

The current TTM revenue of MRTX is $38.19 M

What is the all time high TTM revenue for Mirati Therapeutics?

Mirati Therapeutics all-time high TTM revenue is $78.16 M

What is Mirati Therapeutics TTM revenue year-on-year change?

Over the past year, MRTX TTM revenue has changed by +$26.39 M (+223.63%)